The American Kidney Fund strongly supports the Chronic Kidney Disease Improvement in Research and Treatment Act of 2015 (H.R. 1130, S. 598).

Introduced in February 2015 by Representatives Tom Marino (R-PA), John Lewis (D-GA) and Peter Roskam (R-IL) in the House and Senators Ben Cardin (D-MD), Mike Crapo (R-ID) and Bill Nelson (D-FL) in the Senate, this legislation would improve the coordination of patient care through a variety of measures. H.R. 1130, S.598 would:

  • Allow individuals under 65 with kidney failure to enroll in Medicare Advantage plans.
  • Expand patient access to kidney disease education programs and home dialysis treatment options.
  • Address kidney disease research, setting the nation on the path toward a cure through efficiently managed and coordinated biomedical research. It would require the GAO to assess the adequacy of federal funding for CKD research relative to the expenditures for CKD care and identify gaps in research.
  • Mandate a federal study to better understand the progression of kidney disease and treatment of kidney failure in minority populations.

There are currently 60 co-sponsors in the House of Representatives, and 10 co-sponsors in the Senate. Continue to urge your elected officials to support this important piece of legislation by visiting our online Action Center.